Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index

AIDS Research and Therapy

Volumn 4, Issue , 2007, Pages

  Moore, David M ^a,b,c   Awor, Anna ^a   Downing, Robert S ^a   Were, Willy ^a   Solberg, Peter ^a,d   Tu, David ^e   Chan, Keith ^b   Hogg, Robert S ^b,c   Mermin, Jonathan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEMOGLOBIN;

ACCURACY; ADULT; ALGORITHM; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG INDICATION; FALSE POSITIVE RESULT; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RESOURCE MANAGEMENT; SENSITIVITY ANALYSIS; UGANDA;

EID: 33847178318     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-4-1     Document Type: Article

References (22)

1. World Health Organization Scaling up antiretroviral therapy in resource limited settings: Guidelines for a Public Health Approach Geneva:, WHO 2003
2. World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: Towards universal access. Geneva, Switzerland., World Health Organization, 2006 2006 March 3, 2006.
3. Tassie JM Marquardt T Damisoni H Odhiambo OD Mulemba M Szumilin E Legros D Indirect markers to initiate highly active antiretroviral therapy in a rural African setting Aids 2004 18 8 1226-1228 10.1097/ 00002030-200405210-00025 15166547
4. Jacobson MA Liu L Khayam-Bashi H Deeks SG Hecht FM Kahn J Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy Aids 2003 17 6 917-919 10.1097/ 00002030-200304110-00019 12660541
5. Kumarasamy N Mahajan AP Flanigan TP Hemalatha R Mayer KH Carpenter CC Thyagarajan SP Solomon S Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries J Acquir Immune Defic Syndr 2002 31 4 378-383 12447007
6. Spacek LA Griswold M Quinn TC Moore RD Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings Aids 2003 17 9 1311-1317 10.1097/00002030-200306130-00005 12799552
7. Schechter M Zajdenverg R Machado LL Pinto ME Lima LA Perez MA Predicting CD4 counts in HIV-infected Brazilian individuals: A model based on the World Health Organization staging system J Acquir Immune Defic Syndr 1994 7 2 163-168 7905525
8. Ferris DC Dawood H Magula NP Lalloo UG Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm(3) in HIV-infected patients in South Africa Aids 2004 18 10 1481-1482 10.1097/ 01.aids.0000131345.99160.28 15199330
9. Hogg RS Yip B Chan KJ Wood E Craib KJ O'Shaughnessy MV Montaner JS Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy Jama 2001 286 20 2568-2577 10.1001/ jama.286.20.2568 11722271
10. Coetzee D Hildebrand K Boulle A Maartens G Louis F Labatala V Reuter H Ntwana N Goemaere E Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa Aids 2004 18 6 887-895 10.1097/ 00002030-200404090-00006 15060436
11. Laurent C Diakhate N Gueye NF Toure MA Sow PS Faye MA Gueye M Laniece I Toure Kane C Liegeois F Vergne L Mboup S Badiane S Ndoye I Delaporte E The Senegalese government's highly active antiretroviral therapy initiative: An 18-month follow-up study Aids 2002 16 10 1363-1370 10.1097/00002030-200207050-00008 12131213
12. Weidle PJ Malamba S Mwebaze R Sozi C Rukundo G Downing R Hanson D Ochola D Mugyenyi P Mermin J Samb B Lackritz E Assessment of a pilot antiretroviral drug therapy programme in Uganda: Patients' response, survival, and drug resistance Lancet 2002 360 9326 34-40 10.1016/ S0140-6736(02)09330-3 12114039
13. Mermin J Lule J Ekwaru JP Malamba S Downing R Ransom R Kaharuza F Culver D Kizito F Bunnell R Kigozi A Nakanjako D Wafula W Quick R Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda Lancet 2004 364 9443 1428-1434 10.1016/S0140-6736(04)17225-5 15488218
14. Vollset SE Confidence intervals for a binomial proportion. Statistics in Medicine 1993 12 809-8824 8327801
15. Etard JF Dieng A Diouf A Thierry-Mieg M Cilote V Taverne B Mboup S Ndoye I Delaporte E Sow P 1290. ARNS Mortality and causes of death in adults receiving HAART in Senegal: A 7-year cohort study.: Feb 5 - 8 2006; Denver, CO. 2006 1
16. Sinkala M Levy J Zulu I Mwango A Stringer E Chi B Reid S Ellerbrock T Bulterys M Stringer J Rapid scale up of antiretroviral services in Zambia: 1-year clinical and immunologic outcomes.: Feb 5 - 8 2006; Denver, CO. 2006 1
17. Yeni PG Hammer SM Hirsch MS Saag MS Schechter M Carpenter CC Fischl MA Gatell JM Gazzard BG Jacobsen DM Katzenstein DA Montaner JS Richman DD Schooley RT Thompson MA Vella S Volberding PA Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel Jama 2004 292 2 251-265 10.1001/jama.292.2.251 15249575
18. Uganda Ministry of Health ORC Macro Uganda HIV/AIDS Sero-behavioural survey 2004 - 2005. Calverton, MD, USA., Uganda Ministry of Health,ORC Macro, 2006
19. Badri M Wood R Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings Aids 2003 17 4 541-545 10.1097/00002030-200303070-00009 12598774
20. Schreibman T Friedland G Use of total lymphocyte count for monitoring response to antiretroviral therapy Clin Infect Dis 2004 38 2 257-262 10.1086/380792 14699459
21. Bedell R Heath KV Hogg RS Wood E Press N Yip B O'Shaughnessy MV Montaner JS Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings Antivir Ther 2003 8 5 379-384 14640384
22. Post FA Wood R Maartens G CD4 and total lymphocyte counts as predictors of HIV disease progression Qjm 1996 89 7 505-508 8759490